Cholesterol Drug

In a first, the non-statin, cholesterol-lowering drug bempedoic acid (Nexletol) has been found to lower the risk of adverse cardiovascular events and death in statin-intolerant patients.

Cholesterol and diabetes drugs were found to lower the prevalence of any type of age-related macular degeneration by 15% and 22%, respectively.

Less than 10% of patients are intolerant to statins, a proportion far lower than previous estimates suggest, according to the world’s largest study of the issue. 

Study participants who took both blood pressure and cholesterol medications were less likely to develop dementia, say investigators.

Despite life‐limiting illness, more than one-third of eldercare facility residents aged 65 and older remain on statins, finds a national study.

People who begin taking statins and blood pressure medications are more likely to stop exercising and gain weight, a new study shows.

Aging may be caused by decreased cellular metabolism … Metabolic syndrome: New use for an old drug … Experimental cholesterol-lowering drug effective when added to statin regimen … Supercentenarians:...

A phone call, email or text successfully prompts statin-takers to fill their first prescription and stick with their medication regimen, say researchers.

The Cleveland Clinic’s Top 10 Medical Innovations for 2020 include a range of discoveries and inventions that target age-related disease.

Funeral services Thursday for top senior living housing and healthcare analyst Tony Mullen, 61 … Vascular issues, not just weight, may increase incontinence among the obese … Study: Newer cholesterol...